Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy

Acinic cell carcinoma is a rare, typically indolent, neoplasm that arises in the salivary glands. Metastatic disease is uncommon, occurring in around 10% of cases. We report the case of a 46-year-old male in whom the first sign of disseminated disease was increased skin pigmentation due to paraneopl...

Full description

Bibliographic Details
Main Authors: Louise Wade MBChB, Paul Kitching MB BCh, FRCPath, Emma De Winton MBBS, FRCR
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/2324709620918080
id doaj-d2342b01076d43f5b328aa35caaeff28
record_format Article
spelling doaj-d2342b01076d43f5b328aa35caaeff282020-11-25T03:39:56ZengSAGE PublishingJournal of Investigative Medicine High Impact Case Reports2324-70962020-05-01810.1177/2324709620918080Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic TherapyLouise Wade MBChB0Paul Kitching MB BCh, FRCPath1Emma De Winton MBBS, FRCR2Royal United Hospitals Bath NHS Foundation Trust, Bath, UKRoyal United Hospitals Bath NHS Foundation Trust, Bath, UKRoyal United Hospitals Bath NHS Foundation Trust, Bath, UKAcinic cell carcinoma is a rare, typically indolent, neoplasm that arises in the salivary glands. Metastatic disease is uncommon, occurring in around 10% of cases. We report the case of a 46-year-old male in whom the first sign of disseminated disease was increased skin pigmentation due to paraneoplastic Cushing’s syndrome. He underwent 3 cycles of chemotherapy with carboplatin and paclitaxel with no symptomatic improvement and a mixed response on imaging. There is no evidence that systemic therapy prolongs survival in metastatic acinic cell carcinoma, and we lack a consensus as to which treatment options are most beneficial. A summary of published evidence regarding choice of palliative chemotherapy regimens and response is discussed in relation to the case.https://doi.org/10.1177/2324709620918080
collection DOAJ
language English
format Article
sources DOAJ
author Louise Wade MBChB
Paul Kitching MB BCh, FRCPath
Emma De Winton MBBS, FRCR
spellingShingle Louise Wade MBChB
Paul Kitching MB BCh, FRCPath
Emma De Winton MBBS, FRCR
Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
Journal of Investigative Medicine High Impact Case Reports
author_facet Louise Wade MBChB
Paul Kitching MB BCh, FRCPath
Emma De Winton MBBS, FRCR
author_sort Louise Wade MBChB
title Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
title_short Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
title_full Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
title_fullStr Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
title_full_unstemmed Ectopic ACTH Secretion Secondary to Metastatic Acinic Cell Carcinoma of the Parotid Gland: A Case Report and Review of Current Evidence for Systemic Therapy
title_sort ectopic acth secretion secondary to metastatic acinic cell carcinoma of the parotid gland: a case report and review of current evidence for systemic therapy
publisher SAGE Publishing
series Journal of Investigative Medicine High Impact Case Reports
issn 2324-7096
publishDate 2020-05-01
description Acinic cell carcinoma is a rare, typically indolent, neoplasm that arises in the salivary glands. Metastatic disease is uncommon, occurring in around 10% of cases. We report the case of a 46-year-old male in whom the first sign of disseminated disease was increased skin pigmentation due to paraneoplastic Cushing’s syndrome. He underwent 3 cycles of chemotherapy with carboplatin and paclitaxel with no symptomatic improvement and a mixed response on imaging. There is no evidence that systemic therapy prolongs survival in metastatic acinic cell carcinoma, and we lack a consensus as to which treatment options are most beneficial. A summary of published evidence regarding choice of palliative chemotherapy regimens and response is discussed in relation to the case.
url https://doi.org/10.1177/2324709620918080
work_keys_str_mv AT louisewadembchb ectopicacthsecretionsecondarytometastaticaciniccellcarcinomaoftheparotidglandacasereportandreviewofcurrentevidenceforsystemictherapy
AT paulkitchingmbbchfrcpath ectopicacthsecretionsecondarytometastaticaciniccellcarcinomaoftheparotidglandacasereportandreviewofcurrentevidenceforsystemictherapy
AT emmadewintonmbbsfrcr ectopicacthsecretionsecondarytometastaticaciniccellcarcinomaoftheparotidglandacasereportandreviewofcurrentevidenceforsystemictherapy
_version_ 1724537503365464064